These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9357349)

  • 21. Case management as a therapeutic enhancement: impact on post-treatment criminality.
    Siegal HA; Li L; Rapp RC
    J Addict Dis; 2002; 21(4):37-46. PubMed ID: 12296500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment illegal activities of a nationwide sample of adolescent substance abuse clients.
    Kinlock TW; Gordon MS; Battjes RJ
    J Psychoactive Drugs; 2004 Mar; 36(1):5-12. PubMed ID: 15152705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.
    Krawczyk N; Feder KA; Saloner B; Crum RM; Kealhofer M; Mojtabai R
    Drug Alcohol Depend; 2017 Jun; 175():157-163. PubMed ID: 28432939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of community substance abuse treatment services on clients' criminal arrests.
    Ventura LA; Lambert EG
    Addict Behav; 2005 Aug; 30(7):1459-63. PubMed ID: 16022942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of centralized intake on outcomes of substance abuse treatment.
    Rohrer JE; Vaughan MS; Cadoret RJ; Carswell C; Patterson A; Zwick J
    Psychiatr Serv; 1996 Nov; 47(11):1233-8. PubMed ID: 8916242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managed care and outpatient substance abuse treatment intensity.
    Lemak CH; Alexander JA
    J Behav Health Serv Res; 2001 Feb; 28(1):12-29. PubMed ID: 11329996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designated case managers as facilitators of medical and psychosocial service delivery in addiction treatment programs.
    Friedmann PD; Hendrickson JC; Gerstein DR; Zhang Z
    J Behav Health Serv Res; 2004; 31(1):86-97. PubMed ID: 14722483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of premorbid cognitive abilities to substance users' problems at treatment intake and improvements with substance abuse treatment and case management.
    Block RI; Bates ME; Hall JA
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):515-38. PubMed ID: 14510038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
    Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
    Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
    Broome KM; Flynn PM; Simpson DD
    Health Serv Res; 1999 Aug; 34(3):791-806. PubMed ID: 10445903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Planned duration of residential drug abuse treatment: efficacy versus effectiveness.
    McCusker J; Bigelow C; Vickers-Lahti M; Spotts D; Garfield F; Frost R
    Addiction; 1997 Nov; 92(11):1467-78. PubMed ID: 9519490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Client-service matching in substance abuse treatment for women with children.
    Smith BD; Marsh JC
    J Subst Abuse Treat; 2002 Apr; 22(3):161-8. PubMed ID: 12039620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment.
    Dodge R; Sindelar J; Sinha R
    J Subst Abuse Treat; 2005 Mar; 28(2):189-96. PubMed ID: 15780549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing readmissions to detoxification: an interorganizational network perspective.
    Spear SE
    Drug Alcohol Depend; 2014 Apr; 137():76-82. PubMed ID: 24529966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Criminal recidivism in three models of mandatory drug treatment.
    Young D; Fluellen R; Belenko S
    J Subst Abuse Treat; 2004 Dec; 27(4):313-23. PubMed ID: 15610833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do drug treatment facilities increase clients' exposure to potential neighborhood-level triggers for relapse? A small-area assessment of a large, public treatment system.
    Jacobson JO
    J Urban Health; 2006 Mar; 83(2):150-61. PubMed ID: 16736365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.